Company profile

Established in June 1995, Qidong Gaitianli Medicines Co., Ltd. is a modern Chinese medicine company specializing in the research and development, manufacturing and sales of proprietary Chinese medicine solid preparations. The plant covers an area of more than 130,000 square meters, the production construction area of more than 100,000 square meters, with a complete set of research and development, cultivation, extraction, granulation and testing in one of the modern production line, the annual production capacity of 9500 tons of huaier fungus and 250 million bags of granule, the company's net assets of more than 500 million yuan, the existing staff of more than 1700 people.

Since its establishment more than 20 years ago, the company has believed in the enterprise development strategy of "concentration, concentration and clustering", devoted itself to the research of tumor treatment and immune disease treatment, which is a worldwide problem, committed to breaking the panic and despair of cancer as a terminal disease, reducing people's helplessness and doubts about various immune diseases, and continued to carry out a large number of basic scientific research and clinical research, and achieved fruitful results. The company's main products are Huaier fungus，Huaier Granule and Huaiqihuang granule, which have obtained a number of national invention patents, national first-class new drug honorary certificate, National Science and Technology Progress third prize and Chinese Medicine science and technology Progress second prize, included in the national Torch Plan project, and were rated as Jiangsu Province famous brand products, famous trademarks and high-tech products.

Huaier Granule is a new anti-cancer drug developed by the company. A large number of basic studies have shown that the key role of Huaier is to reverse stem cells, which are the basis for the treatment of tumors, immune diseases and others. This unique effect, which is not available in other drugs, has broadened the medical community's treatment of these diseases, and made the treatment of related diseases no longer a problem. Therefore, the new strategies for the treatment of tumor and immune diseases proposed by us have sufficient theoretical basis and have made a breakthrough in clinical efficacy. A number of prospective, multicentre and large sample clinical studies have shown that Huaier granules have unique anticancer activity, has a subversive therapeutic effect on liver cancer after surgery, can effectively prevent the recurrence and metastasis of liver cancer after surgery, significantly improve the survival rate of liver cancer after surgery, and has a very good safety. The positive results of clinical studies on the use of Huaier granule alone after radical liver cancer surgery have been proved to be an effective drug to prevent liver cancer recurrence and metastasis after liver cancer surgery in the past 40 years, and it is also the first choice to standardize follow-up treatment and block tumor recurrence, which has been written into the 2017 and 2019 editions of the National Health Commission's "Norms for the Diagnosis and Treatment of Primary Liver Cancer". Guidelines for the Diagnosis and Treatment of Primary Liver Cancer in 2022 and 2024.

Huaiqihuang granule is made of three kinds of medicine, namely, Huaier water extract, wolfberry and solomonseal, and its manufacturing method, pharmaceutical use and application in the treatment of nephropathy have obtained a number of national invention patents. Through the research of many authoritative medical institutions and many experts and scholars in China, it is revealed that Huaiqihuang granules have anti-inflammatory, anti-allergy, promoting blood circulation and removing blood stasis, improving microcirculation, removing obsolete tissues and obvious bidirectional immune regulation effects. A large number of clinical studies have shown that Huaiqihuang granule has a unique and clear effect in the treatment of recurrent respiratory tract infection, asthma, nephrotic syndrome, anaphylactoid purpura and so on.

After more than 20 years of hard work and continuous exploration, Huaier granules and Huaiqihuang granules have achieved exciting authoritative scientific research results in many fields, and their unique, advanced and comprehensive mechanism of action directly confirms their good clinical effects. Since the launch of the two products, the good clinical efficacy and convenience of taking have been widely recognized and strongly recommended by the majority of clinical experts, and have been trusted and welcomed by the majority of patients, and the market sales and market coverage have steadily increased at a rate of about 20% every year.

Innovation is the inexhaustible driving force for human progress. Let us join hands and continue to uphold the enterprise spirit of "dedication, trust-seeking, daring to be the first in the world" of Getianli employees, and make unremitting efforts for human health and create life energy.